Seropositivity of Hepatitis B, Hepatitis C, HIV and VDRL Infections Among Blood Donors in General Kirkuk Hospital

Amaç:Hepatit B ve C için Kerkük'te yüksek oranlar rapor edilmektedir. Bu bölgede kontamine kanın transfüzyonu Hepatit B ve Hepatit C'nin yayılmasında önemli bir etkendir. Bu çalışmanın amacı, Kerkük merkez kan bankasında sağlıklı donörler arasında Hepatit B, Hepatit C, HIV ve VDRL seroprevalansını ve önceki çalışmalarda nakledildiği gibi düşüşe geçip geçmediğini araştırmaktır. Materyal ve Metot: Bu çapraz kesitsel çalışma 1 Eylül 2012 ile 30 Mart 2013 arasında Kerkük Devlet Hastanesi merkezi kan bankası veri tabanının analizi şeklinde, cinsiyet farkı gözetmeden, rastgele seçilen 18-65 yaş arası 1000 donör üzerinde planlanmıştır. Bulgular: Seçilen 1000 donörden Hepatit C, Hepatit B ve VDRL prevalansı sırasıyla % 0.40, 1.60 ve 1.90 idi. Bu çalışmada HIV bulgusuna rastlanmamıştır. Sonuç: Hastalara transfüzyon yapılmadan önce kan numunesi en son tekniklerle taranmalıdır

Kerkük Devlet Hastanesinde Kan Donörleri Arasında Hepatit B, Hepatit C, HIV ve VDRL Seropozitifliği

Objectives: Alarming seropositivity rates for Hepatitis B and C are reported in Kirkuk city.Transfusion of contaminated blood is an important cause of Hepatitis B and C spread in this region. The aim of this study was to determine the seroprevalance of Hepatitis B, Hepatitis C, HIV and VDRL among healthy blood donors in central blood bank in Kirkuk and to determine whether the trend of seropositivity is on the decline as indicated by previous studies. We acknowledge all the staff members of blood bank unit in General Kirkuk Hospital for their technical support during data collection. Materials and Methods: This cross sectional study is an analysis of database at central blood bank in General Kirkuk Hospital from1st September 2012 to 30th March 2013 .It was carried out on 1000 blood donors selected randomly, irrespective of gender. The patients' age ranged from 18-65 years. Results: Of the 1000 donors selected randomly, it was reported that seroprevalance of Hepatitis C, Hepatitis B and VDRL was respectively; 0.40%, 1.6%, and 1.90%. No case of HIV was reported in this study. Conclusion: It is recommended that blood should be screened properly by most recent techniques prior to transfusion to the patients

PDF

___

Seeger C, Mason WS. Hepatitis B virus Biology. Microbiology and molecular biology reviews. J ASM 2000:64 (1): 51-68.
Kamal GI. Pathogenic features of chronic hepatitis. Am J Clin Pathol 2000: 113 : 40- 55.
Singh V, Wal N ,Venkatesh V, Tandon R, Singh M, Singh R. Seropositivity rates for hepatitis B and C viruses in a Tertiary Care Centre of Northern India. Webmed Central VIROLOGY 2010;1(11):WMC001197. (doi: 10.9754/journal.wmc.2010.001197).
Seva O, Gulcin Y, CaferiTayyar S, Ahmet K , Resul B. Hepatitis B, hepatitis C, HIV, and VDRL seroprevalance of blood donors in Mersin, Turkey. Turk J Med Sci 2011:41 (2):335-41.
Claude D. Hepatitis program, hepatitis b risk factor, annual report available online http://www.pinellashealth.com/Hepatitis_B.asp (Date of access: September 2014).
Tagny CT, Diarra A, Yahaya R. Characteristics of blood donors and donated blood in sub- saharanFrancophone.Transfusion 2009: 49: 1592-9.
Qasmi SA, Aqeel S, Ahmad M, Alam IS, Ahmd A. Detection of hepatitis B viruses in normal individuals of Karachi. JCPSP 2000: 10(12): 467-9.
Ayele W, Nokes DJ, Abebe A et al. Higher prevalence of anti-HCV antibodies among HIV positive compared to HIV-negative inhabitants of addis . J Med Viro 2002:68:12-7.
Akhtar S, Younus M, Adil S, Jafri SH, Hassan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi. Pakistan Journal of Viral Hepatitis 2004;11:527-35.
Murray P, Rosenthal K, Kobayashi G, Pfaller M. Medical Microbiology. St. Loius: Mosby; 2002:379- 80.
Schleeselman JJ, Stolley PO. Case Control Study, Design, Conduct, Analysis. New York: Oxford University Press; 1982.
Kadir MA, Ismail A M , Tahir S S. Seropositivity of hepatitis B and C among different groups of population in Al-Tameem province, Iraqi. J Comm Med 2001;14:21-4.
Kadir MA, Ismail AM, Tahir SS. Prevalence of hepatitis B and C among people attending Kirkuk public health laboratory. Scientific Journal AL-TAQANI , 2010;23 (3): 6 -15.
Kaitano AE. Prevalence of hepatitis B surface antigen (HBsAg) and hepatitis C (HCV) in Salahdeen province. Diploma dissertation, College of Medicine, Tikrit University, 1996.